BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33957207)

  • 1. The role and mechanism of hyperoside against myocardial infarction in mice by regulating autophagy via NLRP1 inflammation pathway.
    Yang Y; Li J; Rao T; Fang Z; Zhang J
    J Ethnopharmacol; 2021 Aug; 276():114187. PubMed ID: 33957207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the role and mechanism of hyperoside against cardiomyocyte injury in mice with myocardial infarction based on JAK2/STAT3 signaling pathway.
    Rao T; Tong H; Li J; Huang J; Yin Y; Zhang J
    Phytomedicine; 2024 Jun; 128():155319. PubMed ID: 38518637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperoside alleviates epilepsy-induced neuronal damage by enhancing antioxidant levels and reducing autophagy.
    Cao J; Tang C; Gao M; Rui Y; Zhang J; Wang L; Wang Y; Xu B; Yan BC
    J Ethnopharmacol; 2020 Jul; 257():112884. PubMed ID: 32311482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
    Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
    Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total flavonoids from Anchusa italica Retz. Improve cardiac function and attenuate cardiac remodeling post myocardial infarction in mice.
    Wang S; Zhao Y; Song J; Wang R; Gao L; Zhang L; Fang L; Lu Y; Du G
    J Ethnopharmacol; 2020 Jul; 257():112887. PubMed ID: 32315737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperoside prevents sepsis-associated cardiac dysfunction through regulating cardiomyocyte viability and inflammation via inhibiting miR-21.
    Zhang J; Liu Y; Liu L
    Biomed Pharmacother; 2021 Jun; 138():111524. PubMed ID: 34311527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP9 inhibition increases autophagic flux in chronic heart failure.
    Nandi SS; Katsurada K; Sharma NM; Anderson DR; Mahata SK; Patel KP
    Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1414-H1437. PubMed ID: 33064567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
    Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
    Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy.
    Zhang YJ; Yang SH; Li MH; Iqbal J; Bourantas CV; Mi QY; Yu YH; Li JJ; Zhao SL; Tian NL; Chen SL
    Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):995-1002. PubMed ID: 25224725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Xin-Ji-Er-Kang on heart failure induced by myocardial infarction: Role of inflammation, oxidative stress and endothelial dysfunction.
    Hu J; Cheng P; Huang GY; Cai GW; Lian FZ; Wang XY; Gao S
    Phytomedicine; 2018 Mar; 42():245-257. PubMed ID: 29655692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone mediates cardioprotection against postinfarction remodeling and dysfunction through the IGF-1/PI3K/AKT signaling pathway.
    Zeng B; Liao X; Liu L; Zhang C; Ruan H; Yang B
    Life Sci; 2021 Feb; 267():118977. PubMed ID: 33383053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
    Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
    Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
    Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
    Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of muscone on cardiac remodeling in a mouse model of myocardial infarction.
    Wang X; Meng H; Chen P; Yang N; Lu X; Wang ZM; Gao W; Zhou N; Zhang M; Xu Z; Chen B; Tao Z; Wang L; Yang Z; Zhu T
    Int J Mol Med; 2014 Jul; 34(1):103-11. PubMed ID: 24807380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lin28a protects against postinfarction myocardial remodeling and dysfunction through Sirt1 activation and autophagy enhancement.
    Hao Y; Lu Q; Yang G; Ma A
    Biochem Biophys Res Commun; 2016 Oct; 479(4):833-840. PubMed ID: 27693787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role and Mechanism of Hyperoside against Depression-like Behavior in Mice via the NLRP1 Inflammasome.
    Song A; Wu Z; Zhao W; Shi W; Cheng R; Jiang J; Ni Z; Qu H; Qiaolongbatu X; Fan G; Lou Y
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen Receptor β Activation Protects Against Myocardial Infarction via Notch1 Signalling.
    Du M; Shan J; Feng A; Schmull S; Gu J; Xue S
    Cardiovasc Drugs Ther; 2020 Apr; 34(2):165-178. PubMed ID: 32157565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sitagliptin improves cardiac function after myocardial infarction through activation of autophagy in streptozotocin-induced diabetic mice.
    Gu Y; Ma CT; Gu HL; Shi L; Tian XT; Xu WQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8973-8983. PubMed ID: 30575942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous miR-144 reduces left ventricular remodeling after myocardial infarction.
    Li J; Cai SX; He Q; Zhang H; Friedberg D; Wang F; Redington AN
    Basic Res Cardiol; 2018 Aug; 113(5):36. PubMed ID: 30084039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spermidine-enhanced autophagic flux improves cardiac dysfunction following myocardial infarction by targeting the AMPK/mTOR signalling pathway.
    Yan J; Yan JY; Wang YX; Ling YN; Song XD; Wang SY; Liu HQ; Liu QC; Zhang Y; Yang PZ; Wang XB; Chen AH
    Br J Pharmacol; 2019 Sep; 176(17):3126-3142. PubMed ID: 31077347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.